Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi(Harvard University), Rizwan Romee(Harvard University), Sharmila Chamling(Harvard University), Corey Cutler(Dana-Farber Cancer Institute), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Leutz Buon(Harvard University), Mahasweta Gooptu(Dana-Farber Cancer Institute), Haesook T. Kim(Dana-Farber Cancer Institute), Catherine J. Wu(Broad Institute), Yohei Arihara(Sapporo Medical University), Joseph H. Antin(Texas Oncology), Robert J. Soiffer(Dana-Farber Cancer Institute), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tomohiro Kubo(Sapporo Medical University), Sarah Nikiforow(Otsuka (Japan)), Carol Reynolds(Harvard University), Jerome Ritz(Harvard University)
Cited by 109
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Towards personalized, tumour-specific, therapeutic vaccines for cancer
|Nature reviews. Immunology|2017|1k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916